Tu MSc - OncoSec Medical VP Operations
| ONCSDelisted Stock | USD 0.06 0 3.63% |
Insider
Tu MSc is VP Operations of OncoSec Medical
| Phone | 855 662 6732 |
| Web | https://oncosec.com |
OncoSec Medical Management Efficiency
The company has return on total asset (ROA) of (0.9284) % which means that it has lost $0.9284 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.1017) %, meaning that it created substantial loss on money invested by shareholders. OncoSec Medical's management efficiency ratios could be used to measure how well OncoSec Medical manages its routine affairs as well as how well it operates its assets and liabilities.OncoSec Medical currently holds 6.17 M in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. OncoSec Medical has a current ratio of 4.42, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about OncoSec Medical's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Chester III | Revelation Biosciences | 45 | |
| Pablo MD | ZyVersa Therapeutics | N/A | |
| Sharon McBrayer | Palisade Bio | N/A | |
| James Rolke | Revelation Biosciences | 56 | |
| MBA MD | Immix Biopharma | 49 | |
| Jason Davis | Virax Biolabs Group | 53 | |
| Jonathan Rothbard | 180 Life Sciences | 71 | |
| Gordon JD | Quoin Pharmaceuticals Ltd | 61 | |
| Tomasz George | Virax Biolabs Group | 40 | |
| JD MBA | Immix Biopharma | N/A | |
| Raphael Mechoulam | 180 Life Sciences | N/A | |
| Karen Cashmere | ZyVersa Therapeutics | 73 | |
| Cameron Shaw | Virax Biolabs Group | 37 | |
| Denise Carter | Quoin Pharmaceuticals Ltd | 56 | |
| Annie Rasmussen | Allarity Therapeutics | 67 | |
| Joan Brown | Allarity Therapeutics | 70 | |
| Dr MedSc | Phio Pharmaceuticals Corp | 68 | |
| MD FAAAAI | Palisade Bio | N/A | |
| Gerald Proehl | Dermata Therapeutics | 66 | |
| Michael Myers | Quoin Pharmaceuticals Ltd | 63 | |
| Gabriel BA | Immix Biopharma | 38 | |
Management Performance
| Return On Equity | -4.1 | |||
| Return On Asset | -0.93 |
OncoSec Medical Leadership Team
Elected by the shareholders, the OncoSec Medical's board of directors comprises two types of representatives: OncoSec Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OncoSec. The board's role is to monitor OncoSec Medical's management team and ensure that shareholders' interests are well served. OncoSec Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OncoSec Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert CPA, VP Controller | ||
| Kim Jaffe, Assistant Operations | ||
| Robert Arch, CEO Pres | ||
| Tu MSc, VP Operations | ||
| CPA CFA, Exec CFO | ||
| Mai MD, Consultant | ||
| Sandra Aung, Sr Officer |
OncoSec Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is OncoSec Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.1 | |||
| Return On Asset | -0.93 | |||
| Current Valuation | 5.6 M | |||
| Shares Outstanding | 5.96 M | |||
| Shares Owned By Insiders | 28.01 % | |||
| Shares Owned By Institutions | 5.83 % | |||
| Number Of Shares Shorted | 192.06 K | |||
| Price To Earning | (3.12) X | |||
| Price To Book | 0.78 X | |||
| EBITDA | (35.92 M) |
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |